A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Clinical trial NCT07532265 · RECRUITING
Trial details
- NCT number
- NCT07532265
- Sponsor
- Kinaset Therapeutics Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-16
- Primary completion
- 2027-11-30
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.